Durex nixes nonoxynol-9
Condom marketer will discontinue the use of the spermicide nonoxynol-9 in manufacturing its Durex condom line due to an anticipated "material reduction in demand for spermicidally lubricated condoms," SSL International announces recently. The decision follows a report by the World Health Organization "which questioned the level of additional protection provided by such condoms when compared to non-spermicidally lubricated condoms," London-based company says. The WHO's June 2002 report also recommended evaluating the safety of spermicides following research that showed their use may increase the risk of STD transmission (1"The Tan Sheet" July 8, 2002, p. 17)...
More from Archive
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.
The Trump Administration’s rhetoric and policy approaches illustrate the confusion that often arises between efforts to cut drug prices and cutting spending.
Companies with significant exposure to Medicare and Medicaid have fewer options for passing along higher costs to consumers because of price controls in the programs.